Intima-media thickening in patients with familial Mediterranean fever

Serdal Ugurlu1, Emire Seyahi, Firat Cetinkaya

  • 1Department of Internal Medicine, Medical Faculty of Cumhuriyet University, Sivas, Turkey.

Abstract

Insights

Patients with Familial Mediterranean Fever (FMF) show increased intima-media thickness (IMT) but not atherosclerotic plaques. Further research is needed to understand the significance of elevated IMT in FMF patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Vascular Biology

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disease.
  • Subclinical atherosclerosis assessment is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To evaluate the prevalence of atherosclerotic plaques and intima-media thickness (IMT) in FMF patients.
  • To compare atherosclerosis markers between FMF patients, Systemic Lupus Erythematosus (SLE) patients, and healthy controls.

Main Methods:

  • 100 FMF patients, 94 SLE patients, and 103 healthy controls were included.
  • Carotid (C-IMT) and femoral artery intima-media thickness (F-IMT) were measured using B-mode ultrasonography.
  • Atherosclerotic plaques and traditional risk factors were assessed.

Main Results:

  • Both FMF and SLE patients exhibited significantly higher C-IMT and F-IMT compared to controls, even after risk factor adjustment.
  • A higher frequency of atherosclerotic plaques was observed in SLE patients but not in FMF patients.
  • In FMF, plaque presence was linked to diabetes mellitus; IMT correlated with age, BMI, and fasting glucose.

Conclusions:

  • Increased atherosclerosis, defined by plaque presence, was not found in FMF patients.
  • The clinical significance of elevated C-IMT and F-IMT in FMF patients requires further investigation.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...